<?xml version="1.0"?>

<document>
	<title>Further studies on lymphocyte beta-glucuronidase abnormality in
   cystic fibrosis.  Possible relations to carboxypeptidase B-like
   activity.</title>

	<author>Marchi-A-G.</author>
	<author>Marchi-M-A.</author>
	<author>Cigui-I.</author>
	<author>Uxa-F.</author>
	<author>Perticarari-S.</author>
	<author>Nordio-S.</author>

	<source>Helv-Paediatr-Acta. 1978 Dec. 33(6). P 517-25.</source>

	<abstract>The presence in the serum of both cystic fibrosis (CF) homozygotes
   and heterozygotes of a factor inhibiting the response of lymphocyte
   lysosome beta-glucuronidase activity to in vitro phytohaemagglutinin
   (PHA) stimulation is confirmed. Studying lymphocyte beta-
   glucuronidase activity on PHA stimulation represents a way to confirm
   CF diagnosis and to screen CF heterozygotes. For technical
   complexity, however, the method cannot be used for mass screening,
   but it can be useful for confirming the diagnosis in suspected cases.
   Relationships between serum factor inhibiting the effect of PHA on
   beta-glucuronidase, ciliary dyskinesia factor and carboxypeptidase B-
   like activity are discussed.</abstract>

	<majorsubject>CARBOXYPEPTIDASES: bl</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: en</majorsubject>
	<majorsubject>GLUCURONIDASE: bl</majorsubject>
	<majorsubject>LYMPHOCYTES: en</majorsubject>

	<minorsubject>CHILD</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: di, fg</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HETEROZYGOTE</minorsubject>
	<minorsubject>HOMOZYGOTE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>LYMPHOCYTE-TRANSFORMATION</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PHYTOHEMAGGLUTININS: pd</minorsubject>

	<reference>001   CONOVER JH            LANCET                           2  1501 973</reference>
	<reference>002   CONOVER JH            PEDIATR RES                      7   220 973</reference>
	<reference>003   CONOVER JH            PEDIATR RES                      7   224 973</reference>
	<reference>004   CONOVER JH            LIFE SCI                        14   253 974</reference>
	<reference>005   DI SANTAGNESE PA      N ENGL J MED                   295   481 976</reference>
	<reference>006   ERDOS EG              BIOCHEM PHARMACOL               13   893 964</reference>
	<reference>007   FOLK JE               J BIOL CHEM                    235  2272 960</reference>
	<reference>008   LIEBERMAN J           AM REV RESPIR DIS              111   100 975</reference>
	<reference>009   LIEBERMAN J           AM REV RESPIR DIS              116  1047 977</reference>
	<reference>010   MANGIAROTTI-MARCHI MA MINERVA PEDIATR                 23  1847 971</reference>
	<reference>011   MARCHI AG             MINERVA PEDIATR                 23  1842 971</reference>
	<reference>012   MARCHI AG             HELV PAEDIATR ACTA              28   427 973</reference>
	<reference>013   MARCHI AG             ACTA PAEDIATR BELG              29    67 976</reference>
	<reference>014   NORDIO S              ACTA PAEDIATR SCAND             63   664 974</reference>

	<citation>1   JAKEL HP              BIOL ZENTRALBL                 100   273 981</citation>

</document>
